Patienternes immunrespons over for spormængder af kontaminerende proteiner blev analyseret ved at undersøge titere for antistoffer mod disse proteiner, laboratorieparametre og rapporterede bivirkninger.
The patient’ s immune response to trace amounts of contaminating proteins was analysed by examining titres of antibodies to these proteins, laboratory parameters and reported adverse events.